Latest Pacira Pharmaceuticals Inc. Stories
NEW YORK, Sept.
NEW YORK, Sept. 25, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Pacira Pharmaceuticals, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX).
National Patient Safety Foundation Program Aligns Stakeholders from Across Health Care in a Unifying Mission Boston, MA (PRWEB) February 21, 2014 The
IMPROVE trial compares the cost of care between a standard opioid-based regimen and an EXPAREL-based multimodal regimen for postsurgical pain management. Online
- totally perplexed and mixed up.